Intravenous Administration: Delivered directly into the bloodstream, this method is typically used for individuals with certain conditions, such as diabetes or Parkinsons disease
Past or Future concerns
The RNAprotein complexes were captured on Dynabead protein A (Thermo Fisher, 10006D) at 4 C for 90 min, washed with NT2 buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM MgCl 2 and 0.05% NP-40) and then incubated in NT2 buffer containing DNase I (Qiagen, 79254) at 37 C for 10 min
Animal studies show substantial evidence across stroke models (full functional recovery in spatial memory, motor coordination, balance), Parkinsons models (protection of dopaminergic neurons, near-complete prevention of mortality), multiple sclerosis models (significantly less brain damage), and traumatic brain injury (reduced hemorrhage and edema)